Sexually Transmitted Disease Testing Market Trends

  • Report ID: 4461
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Sexually Transmitted Disease Testing Market Growth Drivers and Challenges:

Growth Drivers

  • Insurance Policy for STD Testing and Treatment - In many cases, health insurance companies offer urgent care STD testing. As a result, patients with limited financial resources are expected to benefit from these policies, which are estimated to contribute to market growth. For instance, the Affordable Care Act (ACA) requires that most private insurance plans and public health coverage projects, such as Medicaid, encompass STI screening and counseling at no cost.

  • Rise in Global Population of Young Adults - Young adults are generally more curious, both sexually and socially active. As a result, their broadened mentality leads them to engage sexually with more partners, therefore, they are more susceptible to STDs. This trend is expected to fuel the STD Testing Market growth over the forecast period. By the statistics of the WHO, globally one in 20 young people catches STD each year. The rate is higher among the age group of 20-24 years.

  • Alarming Elevation in the Number of Rape Cases and Sexual Harassment - According to the WHO, every 1 in 3 women experience sexual violence at least once in their lifetime worldwide.
  • Rising Prevalence of Sexually Transmitted Disease (STD) - Cases of sexually transmitted is rising owing to people's active sexual life, choices of multiple partners and not using contraceptives. According to a World Health Organization report released in November 2021, over 1.0 million sexually transmitted infections are obtained globally, with the majority of them being asymptomatic. It also stated that approximately 374.0 million new infections with one of four sexually transmitted infections occurring annually: gonorrhea, chlamydia, trichomoniasis, and syphilis. As a consequence of the growing frequency and prevalence rate of sexually transmitted diseases around the world, the requirement for STD diagnostics is anticipated to rise, expanding market growth during the forecast period.

Challenges

  • Social Stigma Sticked with Sexually Transmitted Diseases - There is a huge share of the population, that hesitates to talk about sex or go for STD testing and treatment. Sexually transmitted disease is proven to be a common disease, despite the social stigma surrounding STDs, still exists. Even after the rise in the educated population, people have a false notion about sex or sex-related problems. Therefore, the rising social stigma is expected to hinder market growth.

  • Higher Cost of Systems Required for STD Detection

  • Inaccurate Result by Detection Systems

Base Year

2025

Forecast Period

2026-2035

CAGR

8.3%

Base Year Market Size (2025)

USD 10.77 billion

Forecast Year Market Size (2035)

USD 23.91 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of sexually transmitted disease testing is assessed at USD 11.57 billion.

The global sexually transmitted disease testing market size was valued at over USD 10.77 billion in 2025 and is expected to expand at a CAGR of around 8.3%, surpassing USD 23.91 billion revenue by 2035.

The Asia Pacific sexually transmitted disease testing market holds the largest share by 2035, driven by increasing STDs linked to sexual crimes and lack of sex education.

Key players in the market include Abbott Laboratories, bioMerieux, Becton Dickinson and Company, Quest Diagnostics, Thermo Fisher Scientific, Hologic Inc., Orasure Technologies, Inc., S&P Global, DiaSorin Molecular LLC.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos